Health & Wellness

It’s hard to keep track of when to start getting screened for health issues. Here’s a guide.

The FTC hasn’t often challenged mergers involving drugmakers, but under Chair Lina Khan it has taken a stricter stance on deals.

Research linking processed meat to health problems has many doctors urging people to skip deli meat, bacon and sausage.

The U.S. has ended its crisis response to the pandemic. But for people with long Covid, the struggles aren’t over.

Big clinics are giving Leqembi to some patients while rural providers said they would wait.

The maker of the weight-loss version of Ozempic has limited starter-dose supplies in the U.S. to protect supplies for current users.

Based on the new data, Lilly said it plans to apply this quarter to the FDA for approval to market the drug.

Many women in their 40s and 50s notice their weight starts to creep up. There’s a reason.

Longevity seekers are captivated by a transplant drug called rapamycin, but many doctors are wary.

The games run by the boss of Savills North America serve as both exercise and networking events for players from their teens to their 80s.

A potential second term by America’s oldest president puts age and health in the spotlight.

Chief Commercialization Officer Christopher Boerner will take over after Giovanni Caforio retires, the company said.

Pollen season is starting earlier and hitting harder, irritating even people who don’t usually suffer.

Adding Ozempic and Mounjaro to federal plans, whose prescription benefit excludes weight drugs, could stoke sales.

A cadre of hard-core endurance athletes are embracing skyrunning, which focuses on how high you can run instead of how far.

Only 12% of respondents in a recent WSJ poll said they were “very happy.” We called to ask what makes them different.

Apps are luring workers to open shifts with higher pay and shorter hours.

The struggle to find Adderall, other stimulants or generics is one of a series of rolling drug shortfalls during the past year.

A unit of the health-products company is also refiling for bankruptcy protection to seek approval for the settlement plan.

Colon cancer rates are rising among younger people, yet many Americans don’t realize they should start screenings at age 45.